283 related articles for article (PubMed ID: 16790193)
1. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
Maron BJ
Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
[No Abstract] [Full Text] [Related]
2. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
Maron BJ
Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
[No Abstract] [Full Text] [Related]
3. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
[TBL] [Abstract][Full Text] [Related]
4. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
Cotiga D; Ehlert F; Sherrid M
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
[TBL] [Abstract][Full Text] [Related]
5. Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
[TBL] [Abstract][Full Text] [Related]
6. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
[No Abstract] [Full Text] [Related]
7. Can sudden cardiac death be prevented?
Maron BJ
Cardiovasc Pathol; 2010; 19(6):329-35. PubMed ID: 20378375
[TBL] [Abstract][Full Text] [Related]
8. Implantable defibrillators in hypertrophic cardiomyopathy.
Grace A
Heart; 2009 May; 95(9):695-6. PubMed ID: 19282312
[No Abstract] [Full Text] [Related]
9. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
[No Abstract] [Full Text] [Related]
10. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertrophic cardiomyopathy.
Penas-Lado M; Barriales-Villa R; Monserrat L
Circulation; 2003 Apr; 107(16):e110; auhor reply e110. PubMed ID: 12719296
[No Abstract] [Full Text] [Related]
13. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Raj SR; Mitchell LB; Sheldon RS
N Engl J Med; 2000 Jul; 343(1):68-9. PubMed ID: 10896549
[No Abstract] [Full Text] [Related]
14. Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: how to evaluate risk and when to implant a cardioverter-defibrillator?
Woźniak O; Włodarska EK
Cardiol J; 2009; 16(6):588-91. PubMed ID: 19950101
[No Abstract] [Full Text] [Related]
15. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
[No Abstract] [Full Text] [Related]
16. Sudden death in hypertrophic cardiomyopathy.
Watkins H
N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
[No Abstract] [Full Text] [Related]
17. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter defibrillators in children.
Chun TU; Collins KK; Dubin AM
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
[TBL] [Abstract][Full Text] [Related]
20. Device therapy in hypertrophic cardiomyopathy.
Beadle R; Williams L
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
